Ambry Genetics

Industry

  • Digital Health
    • Disease Management
    • Artificial Intelligence
  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Bioinformatics
  • Laboratory Testing Services

Other Names/Subsidiaries

  • Ambry Genetics Corp.
See more in Biomedtracker

Latest on Ambry Genetics

Medtech Insight

Start-Up Spotlight: Seqster Wants To Be The Mint.com Of Your Health-Care Data

 
• By Marion Webb

Seqster's CEO Ardy Arianpour believes his company has solved a problem that even the big tech giants haven't yet figured out – to integrate data from electronic medical records (EHRs), DNA and genomic

In Vivo

Device/Diagnostics Quarterly Deal-Making Statistics, Q4 2017

 
• By Maureen Riordan and Amanda Micklus

Device Transactions Device fundraising in Q4 2017 totaled $2.6 billion, the highest single-quarter value of the year. However, total 2017 financing for the industry declined from 2016: $8.4 billion in

In Vivo

Diagnostics 2018: Steady Progress And The Big Get Bigger

 
• By Mark Ratner

FDA product reviews were the lead story for the year, as Class II device designations emerged for large-panel tumor-profiling assays and direct-to-consumer (DTC) genetic health risk assessment (GHRA)

In Vivo

Device/Diagnostics Quarterly Deal-Making Statistics, Q3 2017

 
• By Amanda Micklus and Maureen Riordan

Device Transactions Financing by device companies in the third quarter of 2017 totaled $2.38 billion, double Q2's $1.2 billion. ( See Exhibit 1. ) Debt again this quarter made up most of the aggregate